课题基金 / 基金详情

A Multi-Centre Non-Inferiority Randomized Controlled Trial of STOPping Cardiac MEDications in Patients with Normalized Cancer Therapy Related Cardiac Dysfunction - The STOP-MED CTRCD Trial

A Multi-Centre Non-Inferiority Randomized Controlled Trial of STOPping Cardiac MEDications in Patients with Normalized Cancer Therapy Related Cardiac Dysfunction - The STOP-MED CTRCD Trial
癌症治疗正常化相关心脏功能障碍患者停止心脏药物治疗的多中心非劣效随机对照试验 - STOP-MED CTRCD 试验
批准号：
489331
负责人：
Thavendiranathan Paaladinesh
金额：
$150.47万
依托单位：
University Health Network (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
未结题
起止时间：
2023-09-01 至 2028-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=489331&lang=en
关键词：
Cardio-Oncology Cardiology Cardiomyopathy Cardiotoxicity Determine New Treatment Paradigms Oncology Patient Reported Outcomes Randomized Controlled Trial

项目摘要

项目成果

Thavendiranathan Paaladinesh的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cancer therapy-related cardiac dysfunction (CTRCD) is when the heart's ability to pump oxygenated blood to the body is compromised. It is a side effect of cancer therapy which can occur as commonly as in 1 in 5 patients. When this occurs, heart medication
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Predicting Risk and Identifying Mechanisms of Cardiotoxicity in Breast Cancer Patients - Application of Novel Biomarkers
  • 批准号：
    435909
  • 项目类别：
    Operating Grants
  • 资助金额：
    $60.19万
  • 财政年份：
    2020
  • 负责人：
    Thavendiranathan Paaladinesh
  • 依托单位：
    Toronto General Hospital
Canada Research Chair - Tier 2
  • 批准号：
    415403
  • 项目类别：
  • 资助金额：
    $43.71万
  • 财政年份：
    2019
  • 负责人：
    Thavendiranathan Paaladinesh
  • 依托单位：
    University of Toronto
Epidemiology, Diagnosis, and Treatment of Cardiac Toxicity in Patients Receiving Cancer Therapy - An "Onco-cardiology" Initiative
  • 批准号：
    340769
  • 项目类别：
    Salary Programs
  • 资助金额：
    $21.86万
  • 财政年份：
    2015
  • 负责人：
    Thavendiranathan Paaladinesh
  • 依托单位：
    University Health Network (Toronto)
Evaluation of Myocardial changes during BReast Adenocarcinoma therapy to detect Cardiotoxicity Earlier with MRI- The EMBRACE-MRI Study
  • 批准号：
    322085
  • 项目类别：
    Operating Grants
  • 资助金额：
    $46.71万
  • 财政年份：
    2015
  • 负责人：
    Thavendiranathan Paaladinesh
  • 依托单位：
    University of Toronto
海外基金